Kezar Life Sciences, Inc.
KZR
$6.24
$0.091.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.23M | -13.70M | -16.56M | -20.22M | -20.31M |
| Total Depreciation and Amortization | 227.00K | 243.00K | 251.00K | 259.00K | 260.00K |
| Total Amortization of Deferred Charges | 37.00K | 42.00K | 159.00K | 66.00K | 64.00K |
| Total Other Non-Cash Items | 1.92M | 1.83M | 2.09M | 2.40M | 1.96M |
| Change in Net Operating Assets | -787.00K | -1.21M | -3.14M | 668.00K | 536.00K |
| Cash from Operations | -9.83M | -12.80M | -17.19M | -16.83M | -17.49M |
| Capital Expenditure | 0.00 | 0.00 | -8.00K | -11.00K | -18.00K |
| Sale of Property, Plant, and Equipment | 9.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.70M | 11.40M | 13.75M | 23.76M | 24.08M |
| Cash from Investing | 15.71M | 11.40M | 13.74M | 23.74M | 24.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.31M | -1.30M | -1.30M | -- | -- |
| Issuance of Common Stock | 0.00 | 35.00K | -- | 47.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.31M | -1.27M | -1.30M | 47.00K | 0.00 |
| Foreign Exchange rate Adjustments | -9.00K | 32.00K | 5.00K | -75.00K | 16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.57M | -2.64M | -4.75M | 6.89M | 6.58M |